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Background
Subcellular targeting of proteins in host cells is one of the
most important issues in protein production. Stability,
folding, and post-translational modifications depend on
where proteins are sorted. Besides secretion, ER appears as
an efficient compartment to accumulate proteins, as dem-
onstrated by the frequent use of K/HDEL fused to the C-
terminus of a protein to retain and accumulate recom-
binant proteins in the endoplasmic reticulum (ER) of the
cell hosts.
Results
We present a novel technology (Zera® assembler peptides)
we have developed for recombinant protein production
based on their in vivo accumulation in ER-derived artificial
storage organelles. The Zera® peptide is a proline-rich
domain of a plant storage protein with a) self-assembling
and b) protein body formation properties. Zera® peptide,
as a fusion partner of proteins of interest, reaches a con-
formation stage that induces the formation of novel dense
organelles derived from the ER : Protein Bodies (PBs). The
recombinant proteins remain stably accumulated within
these PBs in host cells. A family of Zera® fusion proteins
have been engineered and expressed in different eukaryo-
tic systems such as yeast, mammalian cells and plants. In
all systems, recombinant proteins accumulate in the
newly formed PBs where they are protected from degrada-
tion. The high density of these organelles permits to
implement optimized recovery and purification processes
of the protein product, partially by achieving a ultra-high,
pre-purification concentration or the product.
Conclusion
Our results indicate that the Zera® peptide is a powerful
tool for both high accumulation of recombinant proteins
in eukaryotic cells and their recovery from biomass.
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